Cover Image
市場調查報告書

腎硬變症候群:全球臨床實驗趨勢

Nephrotic Syndrome Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 341581
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
腎硬變症候群:全球臨床實驗趨勢 Nephrotic Syndrome Global Clinical Trials Review, H2, 2015
出版日期: 2015年09月10日 內容資訊: 英文 78 Pages
簡介

本報告提供腎硬變症候群相關臨床研究最新趨勢相關分析、疾病與治療方法概要,及G7及E7各國的臨床實驗狀況、各地區與各階段的進行狀況、有潛力的贊助商、各企業及研究機關的研究進行狀況、有潛力的藥劑比較等資訊彙整,為您概述為以下內容的。 ■簡介 ▼腎硬變症候群 ▼本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 主要國家的臨床實驗數量; 中東/非洲地區
    • 主要國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量: 腎硬變症候群臨床實驗數量的尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

各相位臨床實驗數量: G7各國

G7各國的臨床實驗數量:各相位

E7各國的臨床實驗數量: 腎硬變症候群臨床實驗數量的尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

各相位臨床實驗數量: E7各國

E7各國的臨床實驗數量:各相位

各相位臨床實驗數量

  • 各相位的進展中臨床實驗數量

各進展狀況臨床實驗數量

各評估項目臨床實驗數量

未完成的臨床實驗

一定期間採用的實驗人數

贊助商的各種類的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 腎硬變症候群治療藥

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Astellas Pharma Inc.
    • Panacea Biotec Limited
    • Mallinckrodt Plc
    • Novartis AG
    • Retrophin Inc.
    • Chong Kun Dang Pharmaceutical Corp.
    • Accutest Research Laboratories (I) Pvt. Ltd.
    • 旭化成
    • ACE Pharmaceuticals BV
  • 代表性研究機關/醫院臨床實驗概要
    • All India Institute of Medical Sciences
    • Istituto Giannina Gaslini
    • Japanese Study Group for Renal Disease in Children
    • The First Affiliated Hospital of Medical School of Zhejiang University
    • The National Institute of Diabetes and Digestive and Kidney Diseases
    • Erasme Hospital
    • Japanese Study Group of Kidney Disease in Children
    • 琦玉醫科大學
    • Seoul National University Hospital
    • Academic Medical Center

5大臨床實驗簡介

附錄

圖表

目錄
Product Code: GDHC2860CTIDB

GlobalData's clinical trial report, "Nephrotic Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Nephrotic Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Nephrotic Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nephrotic Syndrome
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nephrotic Syndrome
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Nephrotic Syndrome Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Panacea Biotec Limited
      • Clinical Trial Overview of Panacea Biotec Limited
      • Mallinckrodt Plc
      • Clinical Trial Overview of Mallinckrodt Plc
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Retrophin Inc.
      • Clinical Trial Overview of Retrophin Inc.
      • Chong Kun Dang Pharmaceutical Corp.
      • Clinical Trial Overview of Chong Kun Dang Pharmaceutical Corp.
      • Accutest Research Laboratories (I) Pvt. Ltd.
      • Clinical Trial Overview of Accutest Research Laboratories (I) Pvt. Ltd.
      • Asahi Kasei Corporation
      • Clinical Trial Overview of Asahi Kasei Corporation
      • ACE Pharmaceuticals BV
      • Clinical Trial Overview of ACE Pharmaceuticals BV
    • Clinical Trial Overview of Top Institutes / Government
      • All India Institute of Medical Sciences
      • Clinical Trial Overview of All India Institute of Medical Sciences
      • Istituto Giannina Gaslini
      • Clinical Trial Overview of Istituto Giannina Gaslini
      • Japanese Study Group for Renal Disease in Children
      • Clinical Trial Overview of Japanese Study Group for Renal Disease in Children
      • The First Affiliated Hospital of Medical School of Zhejiang University
      • Clinical Trial Overview of The First Affiliated Hospital of Medical School of Zhejiang University
      • The National Institute of Diabetes and Digestive and Kidney Diseases
      • Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases
      • Erasme Hospital
      • Clinical Trial Overview of Erasme Hospital
      • Japanese Study Group of Kidney Disease in Children
      • Clinical Trial Overview of Japanese Study Group of Kidney Disease in Children
      • Saitama Medical University
      • Clinical Trial Overview of Saitama Medical University
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Region, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nephrotic Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Panacea Biotec Limited, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mallinckrodt Plc, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Retrophin Inc., 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Chong Kun Dang Pharmaceutical Corp., 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Accutest Research Laboratories (I) Pvt. Ltd., 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Asahi Kasei Corporation, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by ACE Pharmaceuticals BV, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Istituto Giannina Gaslini, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Study Group for Renal Disease in Children, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The First Affiliated Hospital of Medical School of Zhejiang University, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasme Hospital, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Study Group of Kidney Disease in Children, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Saitama Medical University, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015*

List of Figures

  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nephrotic Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nephrotic Syndrome to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nephrotic Syndrome Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Nephrotic Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nephrotic Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nephrotic Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top